Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

✍ Scribed by Henri Roché; Pierfranco Conte; Edith A. Perez; Joseph A. Sparano; Binghe Xu; Jacek Jassem; Ronald Peck; Thomas Kelleher; Gabriel N. Hortobagyi

• Publisher: Springer US
• Year: 2010
• Tongue: English
• Weight: 378 KB
• Volume: 125
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-010-1251-y